These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8889914)

  • 21. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
    J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extending submarine crew survival by reducing CO2 production with quickly reversible sedation.
    Curley MD; Ferrigno M; Lovrincevic MM; Wylegala J; Lundgren CE
    Aviat Space Environ Med; 2010 Jun; 81(6):537-44. PubMed ID: 20540443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.
    Peng W; Zhou J; Xu M; Feng Q; Bin L; Liu Z
    Trials; 2017 Jul; 18(1):301. PubMed ID: 28673322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs acting at the glycine site on the NMDA receptor as cognitive enhancers in patients with Alzheimer's disease.
    Roesler R; Quevedo J; Walz R; Pizzol FD; Kapczinski F
    Neurology; 1998 Apr; 50(4):1195. PubMed ID: 9566436
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic treatment of cognition in Alzheimer's dementia.
    Farlow MR; Evans RM
    Neurology; 1998 Jul; 51(1 Suppl 1):S36-44; discussion S65-7. PubMed ID: 9674761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepine mediated antagonism of opioid analgesia.
    Gear RW; Miaskowski C; Heller PH; Paul SM; Gordon NC; Levine JD
    Pain; 1997 May; 71(1):25-9. PubMed ID: 9200170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
    Kaufer DI; Cummings JL; Christine D
    J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):1-6. PubMed ID: 8679057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
    Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
    Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
    Le Bars PL
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel Therapies in Hepatic Encephalopathy.
    Alimirah M; Sadiq O; Gordon SC
    Clin Liver Dis; 2020 May; 24(2):303-315. PubMed ID: 32245535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased carbon-11-flumazenil binding in early Alzheimer's disease.
    Pascual B; Prieto E; Arbizu J; Marti-Climent JM; Peñuelas I; Quincoces G; Zarauza R; Pappatà S; Masdeu JC
    Brain; 2012 Sep; 135(Pt 9):2817-25. PubMed ID: 22961552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.
    Weinbroum AA; Flaishon R; Sorkine P; Szold O; Rudick V
    Drug Saf; 1997 Sep; 17(3):181-96. PubMed ID: 9306053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of the behavioral effects of flumazenil in two children with autism.
    Wray JA; Yoon JH; Vollmer T; Mauk J
    J Autism Dev Disord; 2000 Dec; 30(6):619-20. PubMed ID: 11261474
    [No Abstract]   [Full Text] [Related]  

  • 40. Video NeuroImages: Idiopathic Recurring Stupor: An Unusual Clinical Condition Responding to Flumazenil.
    Gómez García A; Navas Vinagre I; Herranz Bárcenas A
    Neurology; 2021 Mar; 96(12):586. PubMed ID: 33441456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.